A preclinical-stage biopharmaceutical company dedicated to the discovery and development of innovative treatments for immuno-oncology.
#Drugdiscovery#GPCR#IO
Success proven by science 👏 This is our firm belief! Our #precisionresearch & collaborations drive #pharma innovation. As leaders in #GPCR#immunooncology, we deliver cutting-edge cancer treatments. Thank you @Biotech_finance for this great article.
Best-in-class also works for choirs!
👏 Congratulations to 24 @DOMAINtx choristers for incredible performance at the solidarity concert organized by @LesBlousesRoses at the home for elderly. Music can help many of us find comfort and inspiration. #cancertreatment#immunooncology
@DOMAINtx announces @EPOorg decision to grant a composition of matter #patent in > 15 European countries for its proprietary EP4 receptor antagonist program, including the candidate DT-9081, solidifying company's position as a leading #innovator in the field of #immunooncology
🚲« Bike to work » June challenge is now over:
🎯@DOMAINtx is in the top 10 ➡️ 9th out of 243
🛣️ Distance covered: nearly 10,000 km
❔ approximately 2.53 tons of CO2 emissions avoided = trip from Paris to La Réunion!
Congratulations to the Team!
@CADR67@strasbourg#Cancer
@gazettelabo Merci Alicia et @gazettelabo. Nous sommes ravis d'avoir pu illustrer la valeur ajoutée du portefeuille de @DOMAINtx comme société leader dans les immunothérapies ciblant les #GPCR et annoncer la nomination du DT-7012 un anticorps anti-CCR8 qui entre en développement réglementaire
Proud to announce the nomination of DT-7012, our best-in-class Treg-depleting CCR8 monoclonal #antibody strengthening our #pipeline of immunotherapies targeting #GPCR. With its potential & fast-track development we aim to optimize #immunotherapy effects. #precisionmedicine#IO
Happy to inaugurate our new HQ with friends & partners from our #innovation ecosystem. At @DOMAINtx we push the boundaries of science to unlock new possibilities in cancer while committing to #SustainableDevelopment. Our new building reflects that. Thank you all for your support.
Inauguration ce soir des nouveaux locaux de Domain Therapeutics au Parc d’Innovation. Une belle histoire de développement d’entreprise, d’innovation et d’esprit d’équipe dans une écosystème fertile, au service de la santé… tous mes vœux ! #innovation#biotech#santé
📣 La Course du Petit Prince
Pour aider la recherche contre les sarcomes : cancers rares des enfants et jeunes adultes pour l’institut Bergonié.
https://t.co/gc2D4aITdz